Georgia R Goodman
Overview
Explore the profile of Georgia R Goodman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goodman G, Overstreet D, Wilson J, OCleirigh C, Boyer E, Meints S, et al.
AIDS Res Hum Retroviruses
. 2024 Dec;
PMID: 39711183
Chronic pain can be complicated by problematic opioid use, which may decrease engagement in care and HIV medication adherence. Pain-related anxiety and catastrophic thinking augment pain severity and interference while...
2.
Vanderkruik R, Goodman G, Blyler A, Ott C, Rivas A, Elopre L, et al.
Sex Reprod Healthc
. 2024 Nov;
42:101043.
PMID: 39546962
Objective: Sexually transmitted infections (STIs), including HIV, are a key contributor to psychological and physical morbidity across the United States (US). African American (AA) women are disproportionately impacted by STIs,...
3.
Chai P, Goodman G, Mohamed Y, Bustamante M, Albrechta H, Lee J, et al.
AIDS Behav
. 2024 Jul;
28(10):3373-3380.
PMID: 38985403
Daily oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, though efficacy depends on adherence. Digital pill systems (DPS) can enable direct, real-time adherence measurement. HIV-negative men who have...
4.
Psaros C, Goodman G, Lee J, Rice W, Kelley C, Oyedele T, et al.
J Int AIDS Soc
. 2024 May;
27(5):e26252.
PMID: 38783534
Introduction: HPTN 083 demonstrated the superiority of long-acting cabotegravir (CAB-LA) versus daily oral emtricitabine/tenofovir disoproxil fumarate (TDF/FTC) as pre-exposure prophylaxis (PrEP) among cisgender men and transgender women who have sex...
5.
Psaros C, Stanton A, Goodman G, Blyler A, Vangel M, Labbe A, et al.
J Health Psychol
. 2024 May;
30(3):434-450.
PMID: 38761072
Aging with HIV often results in psychosocial and health-related challenges for women; however, no resiliency interventions exist for older women with HIV (WWH). WWH aged ≥50 were randomized to 10...
6.
Waldron E, Goodman G, Rivas A, Ott C, Blyler A, McDonald V, et al.
Psychol Health
. 2024 Mar;
:1-20.
PMID: 38441003
Objective: African American (AA) women in the U.S. South experience significant HIV incidence, and efforts to support antiretroviral pre-exposure prophylaxis (PrEP) uptake and maintenance among this group have been insufficient....
7.
Lee J, Browning E, Hokayem J, Albrechta H, Goodman G, Venkatasubramanian K, et al.
J Med Toxicol
. 2024 Mar;
20(2):205-214.
PMID: 38436819
Digital phenotyping is a process that allows researchers to leverage smartphone and wearable data to explore how technology use relates to behavioral health outcomes. In this Research Concepts article, we...
8.
Albrechta H, Goodman G, Oginni E, Mohamed Y, Venkatasubramanian K, Dumas A, et al.
PLOS Digit Health
. 2024 Feb;
3(2):e0000457.
PMID: 38386618
Once-daily oral HIV pre-exposure prophylaxis (PrEP) is an effective strategy to prevent HIV, but is highly dependent on adherence. Men who have sex with men (MSM) who use substances face...
9.
Chai P, Kaithamattam J, Chung M, Tom J, Goodman G, Hasdianda M, et al.
JMIR Cardio
. 2024 Feb;
8:e48971.
PMID: 38358783
Background: Heart failure (HF) affects 6.2 million Americans and is a leading cause of hospitalization. The mainstay of the management of HF is adherence to pharmacotherapy. Despite the effectiveness of...
10.
Goodman G, Carnes T, Albrechta H, Alpert P, Hokayem J, Goldfine C, et al.
Proc Annu Hawaii Int Conf Syst Sci
. 2024 Jan;
57:3211-3221.
PMID: 38213843
Once-daily oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, but its efficacy is dependent on adherence, which can be challenging for men who have sex with men (MSM)...